Literature DB >> 18954906

The use of seclusion in the Netherlands compared to countries in and outside Europe.

Wim A Janssen1, E O Noorthoorn, W J de Vries, G J M Hutschemeakers, H H G M Lendemeijer, G A M Widdershoven.   

Abstract

The use of seclusion in psychiatric practice is a contentious issue in the Netherlands as well as other countries in and outside Europe. The aim of this study is to describe Dutch seclusion data and compare these with data on other countries, derived from the literature. An extensive search revealed only 11 articles containing seclusion rates of regions or whole countries either in Europe, Australia or the United States. Dutch seclusion rates were calculated from a governmental database and from a database covering twelve General Psychiatric Hospitals in the Netherlands. According to the hospitals database, on average one in four hospitalized patients experienced a seclusion episode. The mean duration according to the governmental database is a staggering 16 days. Both numbers seem much higher than comparable numbers in other countries. However, different definitions, inconsistent methods of registration, different methods of data collection and an inconsistent expression of the seclusion use in rates limit comparisons of the rates found in the reviewed studies with the data gathered in the current study. Suggestions are made to improve data collection, to enable better comparisons.

Entities:  

Mesh:

Year:  2008        PMID: 18954906     DOI: 10.1016/j.ijlp.2008.09.002

Source DB:  PubMed          Journal:  Int J Law Psychiatry        ISSN: 0160-2527


  14 in total

1.  [Coercive measures in psychiatric clinics in Germany: current practice (2012)].

Authors:  T Steinert; P Schmid
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

Review 2.  Incidence of seclusion and restraint in psychiatric hospitals: a literature review and survey of international trends.

Authors:  Tilman Steinert; Peter Lepping; Renate Bernhardsgrütter; Andreas Conca; Trond Hatling; Wim Janssen; Alice Keski-Valkama; Fermin Mayoral; Richard Whittington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-09-02       Impact factor: 4.328

3.  One-year incidence and prevalence of seclusion: Dutch findings in an international perspective.

Authors:  Eric Noorthoorn; Peter Lepping; Wim Janssen; Adriaan Hoogendoorn; Henk Nijman; Guy Widdershoven; Tilman Steinert
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-19       Impact factor: 4.328

Review 4.  Morbidity and mortality associated with the utilization of restraints : a review of literature.

Authors:  Maryam Rakhmatullina; Abraham Taub; Theresa Jacob
Journal:  Psychiatr Q       Date:  2013-12

5.  Long-Term Impact of a Tailored Seclusion Reduction Program: Evidence for Change?

Authors:  Patricia S Mann-Poll; Annet Smit; Eric O Noorthoorn; Wim A Janssen; Bauke Koekkoek; Giel J M Hutschemaekers
Journal:  Psychiatr Q       Date:  2018-09

6.  Differences in seclusion rates between admission wards: does patient compilation explain?

Authors:  W A Janssen; E O Noorthoorn; H L I Nijman; L Bowers; A W Hoogendoorn; A Smit; G A M Widdershoven
Journal:  Psychiatr Q       Date:  2013-03

7.  Professionals' attitudes after a seclusion reduction program: anything changed?

Authors:  P S Mann-Poll; A Smit; M van Doeselaar; G J M Hutschemaekers
Journal:  Psychiatr Q       Date:  2013-03

8.  The effects of a nationwide program to reduce seclusion in the Netherlands.

Authors:  Fleur J Vruwink; Cornelis L Mulder; Eric O Noorthoorn; Daan Uitenbroek; Henk L I Nijman
Journal:  BMC Psychiatry       Date:  2012-12-18       Impact factor: 3.630

Review 9.  The use of coercive interventions in mental health care in Germany and the Netherlands. A comparison of the developments in two neighboring countries.

Authors:  Tilman Steinert; Eric O Noorthoorn; Cornelis L Mulder
Journal:  Front Public Health       Date:  2014-09-24

10.  Does experienced seclusion or restraint affect psychiatric patients' subjective quality of life at discharge?

Authors:  Päivi Soininen; Hanna Putkonen; Grigori Joffe; Jyrki Korkeila; Pauli Puukka; Anneli Pitkänen; Maritta Välimäki
Journal:  Int J Ment Health Syst       Date:  2013-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.